3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Clinical trial NCT00129116 · COMPLETED

Trial details

NCT number: NCT00129116
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis

Start date: 2003-03-01
Primary completion: 2003-12-01
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.